Fda Drug Approval Calendar 2023
The major efficacy outcome measure. The pdufa date is 10 months after the drug application has been. To treat adults with relapsed or refractory acute. On july 5, the u.s.
Fda approved drugs archivesjanuary 2023. Updated information (as of january 23, 2023): Food and drug administration formally accepted the companies' biologics license application (bla) for lecanemab, granting it priority review. Center for drug evaluation and research location: